Artificial Intelligence in Healthcare

Walk through almost any large hospital today and the changes are easy to miss, because they are happening inside the computers. Machine learning algorithms now read medical images, flag patients who are quietly getting worse, sift through molecular databases for new drugs, and offer a second opinion on diseases that puzzle even experienced clinicians. The people who build these tools make a bold claim: that AI can make medicine faster, cheaper, and more accurate, and that millions of lives might be saved as a result.

Nowhere has the progress been clearer than in medical imaging. Feed a system enough X-rays, MRI scans, and retinal photographs, and it learns to spot patterns the eye can struggle to catch. Some of these systems now identify conditions such as cancers, diabetic retinopathy, and lung disease with accuracy that matches a specialist, and occasionally beats one. In 2020, a study published in Nature Medicine found that an AI system outperformed radiologists in detecting breast cancer from mammograms.

Drug discovery tells a similar story. Bringing a new medicine to patients has long been slow and expensive work, a process that traditionally takes more than a decade and costs billions of dollars. AI shortens the search by combing through enormous libraries of molecular structures and clinical trial data, pulling out the most promising candidates far faster than a team of human researchers ever could. Scientists have called the arrival of AlphaFold, a system that predicts the three-dimensional structure of proteins, one of the most significant advances in biology in decades.

None of this means the road ahead is smooth. A model can only learn from what it is shown, and that is where the trouble starts. When the training datasets are skewed, say they contain fewer images from patients of certain ethnicities, the finished system tends to perform less well for under-represented groups. That gap has fuelled real worry about fairness in AI-assisted healthcare.

Then there is the awkward matter of blame. Suppose an AI system makes an incorrect diagnosis and a patient is harmed. Who answers for it? The doctor who trusted the recommendation, the hospital that installed the software, or the company that wrote the code? No one is quite sure, and regulatory frameworks in most countries have not yet kept pace with the technology.

For all the unease, ask the doctors and you mostly hear cautious enthusiasm. The common refrain is that the technology should support, rather than replace, human judgement. The best results, many of them argue, come from a division of labour: let AI grind through the time-consuming data analysis, and leave doctors free to handle the parts of care that call for empathy, an understanding of context, and ethical reasoning.